Article

The Impact of Overactive Bladder on the Urology Practice: PHARMACOLOGICAL MANAGEMENT

Download the entire supplement in PDF file format

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Jennifer Robles, MD, discusses the growing interest in HoLEP
Jennifer Robles, MD, discusses the growing interest in HoLEP
Suzanne Merrill, MD, on the rationale for BCG plus PD-1/PD-L1 inhibitors in high-risk NMIBC
Suzanne Merrill, MD, on the rationale for BCG plus PD-1/PD-L1 inhibitors in high-risk NMIBC
Timothy McClure, MD, discusses focal therapy with irreversible electroporation
Timothy McClure, MD, discusses focal therapy with irreversible electroporation
Related Content
Health Canada approves perioperative durvalumab plus chemo for MIBC
August 11th 2025

Health Canada approves perioperative durvalumab plus chemo for MIBC

Hannah Clarke
Pearls & Perspectives: Tailoring BPH Therapies to the Patient, with Utsav Bansal, MD
August 11th 2025

Pearls & Perspectives: Tailoring BPH Therapies to the Patient, with Utsav Bansal, MD

Amy M. Pearlman, MD
FDA accepts NDA for new formulation of piflufolastat F 18 in prostate cancer
August 11th 2025

FDA accepts NDA for new formulation of piflufolastat F 18 in prostate cancer

Hannah Clarke
Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD
August 11th 2025

Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD

Amy M. Pearlman, MD
BCG/ICI combinations offer potential paradigm shift in BCG-naïve NMIBC
August 11th 2025

BCG/ICI combinations offer potential paradigm shift in BCG-naïve NMIBC

Tom Jayram, MD
Intravesical gemcitabine/docetaxel formulation shows encouraging efficacy in NMIBC
August 11th 2025

Intravesical gemcitabine/docetaxel formulation shows encouraging efficacy in NMIBC

Hannah Clarke
© 2025 MJH Life Sciences

All rights reserved.